跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRZ-AMLODIPINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PRZ-AMLODIPINE
Authorized
STANDARD
PRZ-AMLODIPINE
pharmaris canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ec561f91f0e2bf9e
Company
pharmaris canada inc
Type
Standard
Approval Details
Approval Id
ec561f91f0e2bf9e
Drug Approval Canada Name
PRZ-AMLODIPINE
Product Name
PRZ-AMLODIPINE
Status
Marketed
Status Date
2022-10-03
Original Market Date
2022-10-03
Din
02522519
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:28.08
Atc Original
C08CA01 AMLODIPINE
Atc Name
c 08 ca 01
Aig Number
0131437002
Company Name
pharmaris canada inc
Company Address
102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9
Active Ingredients
AMLODIPINE (AMLODIPINE BESYLATE)
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ec561f91f0e2bf9e
Type
Standard
Back to Health Canada Approvals